O-5 Integrating trastuzumab (T), with or without pertuzumab (P), into perioperative chemotherapy (CT) of HER-2+ gastric cancer (GC) - subgroup analyses of EORTC 1203 “INNOVATION”, a collaboration with KCSG and DUCG
Titel:
O-5 Integrating trastuzumab (T), with or without pertuzumab (P), into perioperative chemotherapy (CT) of HER-2+ gastric cancer (GC) - subgroup analyses of EORTC 1203 “INNOVATION”, a collaboration with KCSG and DUCG
Auteur:
Wagner, A. Grabsch, H. Mauer, M. Lorenzen, S. Bouché, O. Thuss-Patience, P. Elme, A. Moehler, M. Romario, U. Fumagalli Kang, Y. Folprecht, G. Martens, U. Guzmán, M. Galán Ducreux, M. García, M. Díez Piessen, G. Collienne, M. Lordick, F.